Targeting B-Cell receptor signaling for anticancer therapy: the Bruton's tyrosine kinase inhibitor ibrutinib induces impressive responses in B-cell malignancies
- PMID: 23045586
- DOI: 10.1200/JCO.2012.44.4281
Targeting B-Cell receptor signaling for anticancer therapy: the Bruton's tyrosine kinase inhibitor ibrutinib induces impressive responses in B-cell malignancies
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
